(0) Write a review
In stock

Thymosin Alpha-1 10mg

Advanced 10mg Immune Modulation Peptide

$52.00

19 products sold in last 24 hours
9 people are viewing this right now
Buy now
QuantityDiscountPrice
3–58%$47.84
6–910%$46.80
10+12%$45.76
Discount is applied automatically at checkout based on the quantity in your cart.
Ask Us
Product Specification Thymosin Alpha-1 10mg / Lyophilized Powder Vial
Biochemical Engine Synthetic Thymic Peptide Fragment (28-Amino Acid Sequence)
Primary Assay Target Investigated for T-cell differentiation pathways, toll-like receptor (TLR) signaling, and cytokine balance modulation
Logistics Profile Temperature-insulated, light-shielded moisture-resistant dispatch with complete tracking

STRICTLY FOR LABORATORY RESEARCH: This synthetic agent is processed strictly for institutional R&D, high-precision in vitro metabolic calibrations, and testing lines. Not for human therapeutic or diagnostic use.

Description

Quick-Reference Overview Matrix

For efficient laboratory evaluation, the matrix below consolidates the core analytical, storage, and cross-reference parameters of Thymosin Alpha-1 10mg.

Core Parameter Technical Summary & Quick Data Internal Cross-Reference
Purity & Grade ≥ 98% HPLC Certified Sterile filtered, lyophilized white powder free from structural degradation. View High-Purity Series →
Primary Target Path Immune System Regulation: Acts as an agonist on TLR2/TLR9 receptors; accelerates cellular defense paths and Th1 cytokine expression. View All Metabolic Peptides →
Storage Protocol Lyophilized: -20°C to -80°C (Up to 24 months). Reconstituted: 2°C to 8°C (Strictly use within 10–14 days). Buy Reconstitution Diluents →
Synergistic Assays Frequently co-evaluated alongside cellular recovery and tissue repair compounds for comprehensive multi-pathway research. Explore Tissue Repair Series →

*Directions: Use the links in the “Internal Cross-Reference” column to navigate between targeted chemical classes and accessory laboratory items. Detailed molecular structures and mixing steps are available in the dedicated sections below.

To assist researchers in selecting the optimal compound for specific cellular assays, the table below provides a comparative analysis of Thymosin Alpha-1 against four widely investigated research peptides. Click on any peptide name to view its specific product formulation.
Peptide Compound Primary Mechanism Core Research Focus Target Receptors Molecular Weight
Thymosin Alpha-1 (This Product) Immune Modulation T-Cell maturation, antiviral paths, and cytokine balance. TLR2 / TLR9 3108.3 g/mol
BPC-157 10mg Angiogenesis & Healing Tissue regeneration, tendon repair, and gut lining integrity. VEGFR2 / EGR-1 1419.5 g/mol
TB-500 10mg Actin Sequestration Cell migration, wound healing, and muscle recovery models. Actin-Binding 4963.5 g/mol
Epitalon 10mg Telomerase Activation Cellular longevity, telomere elongation, and circadian rhythms. Epigenetic DNA 390.4 g/mol

Thymosin Alpha-1 (TA1) is a premium-grade, synthetic peptide fragment comprising 28 amino acids. Originally identified as an endogenous compound isolated from thymus gland tissue, this variant is synthesized to match the natural peptide responsible for modulating cellular immune responses. Our formulation is engineered to the highest analytical standards, explicitly tailored for laboratory research, in vitro diagnostics, and in vivo evaluation.

Thymosin Alpha-1 10mg Overview

ParameterSpecification
Product Format10mg Vial (Lyophilized Powder)
SequenceAc-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Molecular FormulaC129H215N33O55
Molecular Weight3108.3 g/mol
Purity Level≥ 98% (HPLC Monitored)
Physical AppearanceSterile filtered, white lyophilized cake/powder
Core Research FocusT-Cell Maturation, TLR2/TLR9 Signaling, Cellular Immunity

Regulatory Compliance Notice: This product is synthesized, distributed, and intended solely for laboratory research and development purposes. It is strictly not for human therapeutic use, clinical trials, or agricultural applications. Analytical data sheets (HPLC/MS results) are systematically logged per batch and can be verified upon institutional request.

In scientific literature, Thymosin Alpha-1 is widely investigated for its diverse biological effects. Primary research applications focus on how this 28-amino acid peptide impacts cellular response paths. Researchers currently utilize this compound to analyze:

  • Immune System Regulation: Investigating its exact role in T-cell differentiation, maturation, and functional balance.
  • Antiviral Pathways: Analyzing its regulatory impact on viral replication rates and host cellular defense responses.
  • Oncology Research: Studying its potential synergistic mechanisms when combined with other experimental therapeutic agents in cancer research models.

Thymosin Alpha-1 Mechanism of Action

Thymosin Alpha-1 exerts its biological activity primarily by targeting Toll-like receptors (TLRs), specifically acting as an agonist for TLR2 and TLR9 in myeloid dendritic cells. This interaction triggers a downstream signaling cascade that results in the following biological processes:

  1. Promotes the dynamic production and secretion of Th1 cytokines (such as Interferon-gamma and Interleukin-2).
  2. Increases Natural Killer (NK) cell population activity and cytotoxicity levels.
  3. Enhances macrophage-mediated phagocytosis, thereby orchestrating a targeted, coordinated cellular immune response.

Potential Areas of Research

Beyond its classic immunomodulatory profiles, contemporary laboratory studies are expanding the scope of TA1 investigations into broader biomedical fields:

  • Chronic Inflammatory Diseases: Evaluating how the peptide balances pro-inflammatory and anti-inflammatory pathways to mitigate tissue stress.
  • Vaccine Adjuvant Studies: Exploring its ability to enhance and accelerate specific antibody responses to co-administered antigens.
  • Tissue Repair & Regeneration: Investigating potential secondary biological benefits in cellular migration and wound healing models.

Research Overview: Benefits vs. Technical Risks

For laboratory evaluation and experimental design optimization, researchers should weigh the documented biological advantages against the inherent technical risks and limitations of the compound:

Observed Research BenefitsTechnical Risks & Limitations
• Potent Immune Modulation: Highly effective in accelerating T-cell maturation and restoring Th1/Th2 balance in compromised cell cultures.• High Degradation Risk: Highly susceptible to rapid enzymatic degradation if exposed to room temperature beyond transit limits.
• High Selectivity: Specific binding to TLR2 and TLR9 reduces non-targeted receptor background noise during assays.• Narrow Dosage Window: Biphasic dose-responses can obscure data; over-saturation may lead to receptor down-regulation in vitro.
• Synergistic Potential: Demonstrates excellent structural stability when combined with antiviral or secondary signaling compounds.• Reconstitution Sensitivity: Aggressive mechanical shaking breaks peptide chains, rendering the laboratory solution completely inactive.

To prevent premature degradation and maintain the peak structural integrity of the Thymosin Alpha-1 peptide chain, strict adherence to temperature-controlled storage protocols is mandatory:

  • LONG-TERM
    Lyophilized Powder: Store the freeze-dried powder strictly at -20°C or -80°C. Under these conditions, the compound remains stable for up to 24 months.
  • SHORT-TERM
    Transit Stability: The lyophilized vial can withstand ambient room temperatures (up to 25°C) for up to 3 weeks during logistics without structural loss. Refrigerate immediately upon arrival.
  • POST-RECONSTITUTION
    Liquid Solution: Once reconstituted, store the solution strictly between 2°C and 8°C. Utilize the compound within 10 to 14 days. Do not re-freeze dissolved liquid.

Reconstitution Guidelines

Reconstitution must be executed with extreme care in an aseptic laboratory environment to avoid shearing the delicate 28-amino acid structural backbone:

  1. Temperature Equilibrium: Remove the Thymosin Alpha-1 vial from storage and allow it to naturally reach room temperature before initiating the reconstitution process.
  2. Aseptic Preparation: Thoroughly swab the sterile rubber stopper of the vial using a fresh isopropyl alcohol wipe to ensure contaminant-free needle entry.
  3. Diluent Introduction: Using a sterile syringe, slowly introduce a bacteriostatic or sterile water diluent (recommended volume: 1ml to 2ml). Aim the needle directly against the interior glass wall of the vial rather than forcing liquid directly onto the powder cake.
  4. Gentle Dissolution (Do Not Shake): Aggressive mechanical agitation will destroy the chemical bonds. Instead, gently swirl the vial in a slow, circular horizontal motion until the lyophilized cake is completely dissolved into a clear, colorless liquid.

Why Choose PeptidesK?

At PeptidesK, we understand that research integrity depends entirely on chemical purity. We are committed to empowering the international scientific community with unmatched product standards and transparent logistics:
  • ✓ Ultra-High Purity Certified: Every single batch of Thymosin Alpha-1 undergoes rigorous High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to guarantee a purity rating of ≥98%.
  • ✓ Cold-Chain Optimized Logistics: Our packaging is meticulously engineered and padded to buffer external thermal shocks, ensuring the peptide structural backbone remains perfectly intact during transit.
  • ✓ Full Scientific Transparency: We do not hide behind anonymous formulations. Complete analytical documentation and specific Certificates of Analysis (CoA) are systematically archived and available upon institutional request.

Reviews

Be the first to review “Thymosin Alpha-1 10mg”

Your email address will not be published. Required fields are marked *

There are no reviews yet.

Search

Back to Top
Product has been added to your cart
Compare (0)